Introduction

Lead compound optimization usually requires the simultaneous modulation of target activity, solubility, membrane permeability, metabolic stability, and nonspecific binding. A structural change may improve one property while shifting another outside the desired range. For example, basic amines facilitate ionic interactions and salt formation, but excessive basicity may cause a molecule to become highly protonated under physiological conditions. Hydrophobic groups may strengthen binding to a hydrophobic pocket in the target, but they may also increase lipophilicity, plasma protein binding, and metabolic clearance.

Fluorinated 3,3-disubstituted oxetanes provide a structurally compact group of molecular building blocks for this type of multiparameter modulation. In 2025, Litskan et al. introduced fluorine atoms into the oxetane core or adjacent alkyl groups through nucleophilic substitution, deoxyfluorination of alcohols, deoxydifluorination of carbonyl compounds, fluoroiodination, and related methods. They also prepared a series of building blocks bearing reactive handles such as amines, carboxylic acids, and alcohols. Some of these routes could be performed on a gram scale. In the amine-containing matched structures examined by the authors, replacing gem-dimethyl, cyclopropyl, or cyclobutylidene groups with oxetane-based structures reduced the pKₐ of the amine conjugate acid [pKₐ(BH⁺)] by as much as approximately 3 units.[1]

The design value of these building blocks does not arise from simply combining two commonly used motifs, “oxetane” and “fluorine.” Instead, it derives from using their distinct electronic and spatial effects to modulate the following properties within a relatively limited range of structural variation:

① The protonation capacity of an amine;

② The proportions of neutral and ionic forms;

③ Molecular partitioning between aqueous and lipid phases;

④ Metabolic sites susceptible to oxidation or hydrolysis;

⑤ The spatial orientation and accessibility of substituents.

Keywords: fluorinated oxetane; 3,3-disubstituted oxetane; molecular building block; amine basicity; pKₐ; logP; logD; microsomal stability; matched molecular pair

1 Structural Basis of Fluorinated 3,3-Disubstituted Oxetanes

1.1 Oxetane Provides Polarity and Conformational Constraint

Oxetane is a four-membered cyclic ether composed of three carbon atoms and one oxygen atom. Compared with acyclic ethers, the four-membered ring restricts free rotation around the C—C and C—O bonds, giving substituents attached to the ring relatively well-defined spatial orientations. Compared with all-carbon structures such as cyclobutane, the ring oxygen increases local polarity and can function as a hydrogen-bond acceptor and a Lewis base.

The oxetane ring generally adopts a slightly puckered rather than completely planar conformation. Its constrained C—O—C bond angle makes the oxygen lone pairs relatively accessible, giving oxetane appreciable hydrogen-bond-accepting ability. However, oxetanes differ from ketones, esters, and amides in geometry, electron distribution, and hydrogen-bond orientation and therefore cannot be regarded as complete mimics of carbonyl structures.[2,3]

1.2 The 3,3-Disubstituted Structure Forms a Compact Quaternary-Carbon Junction

The 3-position of oxetane lies opposite the ring oxygen. After disubstitution at the 3-position, this carbon atom is bonded to two ring methylene groups and two exocyclic substituents, forming a quaternary carbon center.

This structure has several characteristics:

① Absence of a C—H bond at the 3-position. Direct C—H oxidation is unlikely to occur at the 3-position, although the ring methylene groups and exocyclic substituents may still serve as metabolic sites.

② Capacity to accommodate two exocyclic functional units. One substituent may be used to connect the motif to the parent molecule, while the other may be used to modulate electronic effects, lipophilicity, or subsequent reactivity.

③ 3,3-Disubstitution does not usually create a new stereogenic center. When the other ring positions are unsubstituted and the two pathways around the ring are equivalent, the 3-position generally remains non-stereogenic even when it bears two different exocyclic substituents. If the symmetry of the ring has already been disrupted by substitution elsewhere, stereogenicity must be reassessed.

④ Modification of the spatial and electronic environment around the ring. Substitution at the 3-position can influence the ring-opening reactivity of oxetane, but it does not preclude acid-catalyzed, Lewis acid-activated, or enzymatic ring opening.

1.3 Fluorine Primarily Modulates Electron Distribution

Fluorine in an aliphatic C—F bond is strongly electronegative and can transmit an electron-withdrawing inductive effect through σ bonds. When a fluorinated center is located close to an amine, the electron density on the amine nitrogen decreases, reducing its ability to accept a proton and lowering the pKₐ of the amine conjugate acid.

The effect of fluorine depends on several structural variables:

Fluorinated oxetanes therefore form a structural series that can be compared by varying the position and number of fluorine atoms and their distance from other functional groups.

2 Construction Methods for Fluorinated Oxetane Building Blocks

2.1 Designing Synthetic Routes According to Fluorine Position

The fluorinated structures in the original study can be broadly divided into three categories:

1. Fluorine Located on a One-Carbon Linker Outside the Oxetane Ring

Representative motifs include fluoromethyl and difluoromethyl groups. These structures retain a nonfluorinated oxetane ring and use an exocyclic CHF or CHF₂ unit to modulate electronic effects and lipophilicity.

2. Fluorine Located on a Longer or Branched Alkyl Group

Representative motifs include fluoroethyl and fluoroisopropyl groups. Changes in carbon-chain length and branching allow the distance-dependent effects between fluorine and an amine, carboxylic acid, or other functional group to be compared.

3. Fluorine Located Directly on the Oxetane Core

A fluorine atom on the ring is close to both the ring oxygen and the exocyclic substituents at the 3-position, so its electronic influence is generally more direct. Direct fluorination of the ring must, however, also account for elimination, ring opening, and regioselectivity.

Depending on the target structure, the researchers used nucleophilic substitution, deoxyfluorination, carbonyl deoxydifluorination, fluoroiodination, and related methods, and subsequently converted the resulting intermediates into amine-, carboxylic acid-, and alcohol-containing building blocks.[1]

2.2 Important Reaction Schemes

1. Deoxyfluorination of Alcohols

R–CH(OH)–R′ → R–CH(F)–R′

This reaction converts an alcohol group into a C—F bond and is used to construct a monofluorinated center. Its applicability depends on the degree of substitution of the alcohol, adjacent functional groups, and the tolerance of the oxetane ring to the reaction conditions.

2. Deoxydifluorination of Carbonyl Compounds

R–C(=O)–R′ → R–CF₂–R′

This reaction converts a carbonyl group into a CF₂ unit. The electron distribution, hydrogen-bonding properties, and lipophilicity of CF₂ differ from those of both the original carbonyl group and the corresponding methylene group.

3. Nucleophilic Substitution

R–CH₂–X + Nu⁻ → R–CH₂–Nu + X⁻

Here, X represents a leaving group and Nu⁻ represents a nucleophile. This reaction can be used to introduce nitrogen-, oxygen-, or sulfur-containing functional groups.

4. Fluoroiodination and Subsequent Transformation

3-Methyleneoxetane + fluorine source/electrophilic iodine source → 3-fluoro-3-(iodomethyl)oxetane

The resulting C—I bond can subsequently undergo reduction or nucleophilic substitution. Regioselectivity depends on the substrate structure and reaction conditions.

2.3 Building-Block Utility Depends on More Than Synthetic Accessibility

Building blocks intended for medicinal chemistry research should also meet the following requirements:

① Synthetic starting materials and key intermediates should be reliably available;

② The reaction should be reproducible on a gram scale;

③ The intermediates should have practical purification and storage procedures;

④ Terminal functional groups such as amines, carboxylic acids, or alcohols should be compatible with commonly used coupling reactions;

⑤ The oxetane ring should remain intact during protecting-group removal and subsequent derivatization;

⑥ The route should provide a series of structurally related derivatives suitable for comparative studies.

In another systematic study, Litskan et al. examined the stability of oxetanes under oxidation, reduction, acylation, alkylation, nucleophilic substitution, hydrolysis, bond-forming, and protecting-group-removal conditions and reported more than 100 3,3-disubstituted oxetane building blocks. The study showed that many oxetanes tolerate commonly used synthetic conditions, although their specific stability still depends on the substitution pattern and reaction environment.[2]

3 How Fluorinated Oxetanes Modulate Amine Basicity

3.1 Amine Basicity Should Be Expressed Using the pKₐ of the Conjugate Acid

Amines exist in the following equilibrium in aqueous solution:

BH⁺ ⇌ B + H⁺

Where:

· B represents the unprotonated amine;

· BH⁺ represents the conjugate acid of the amine;

· pKₐ(BH⁺) represents the dissociation pKₐ of the amine conjugate acid.

A higher pKₐ(BH⁺) indicates that the amine accepts a proton more readily and is therefore more basic. A decrease in pKₐ(BH⁺) indicates weaker amine basicity.

3.2 The Ring Oxygen and C—F Bond Jointly Reduce Electron Density on the Amine Nitrogen

The oxygen atom in the oxetane ring exerts an inductive electron-withdrawing effect. When a fluorine atom is positioned close to an amine, the C—F bond can further reduce the electron density on the amine nitrogen.

Ring oxygen and a nearby C—F bond

→ decreased electron density on the amine nitrogen

→ reduced ability of the amine to accept a proton

→ decreased pKₐ(BH⁺)

In the amine-containing matched structures examined in the original study, replacing gem-dimethyl, cyclopropyl, or cyclobutylidene groups with oxetane-based structures reduced the pKₐ of the amine conjugate acid [pKₐ(BH⁺)] by as much as approximately 3 units.[1]

A difference of 3 pKₐ units between amine conjugate acids corresponds to an approximately 10³-fold difference in their acid dissociation constants, Kₐ. Even when the change in structural volume is relatively small, it may markedly alter the protonation ratio of a compound at a given pH.

3.3 Changes in pKₐ Affect Both Solubility and Permeability

When amine basicity decreases, the proportion of the unprotonated form, B, generally increases at the same pH. This change may lead to effects in different directions.

Lowering amine pKₐ is therefore not an independent optimization objective. The appropriate range must be determined by considering the target-binding mode, solubility, permeability, and intracellular distribution together.

4 How Fluorinated Oxetanes Modulate Lipophilicity

4.1 logP and logD Reflect Different Properties

For amine-containing molecules, a structural change may simultaneously alter intrinsic lipophilicity and the protonation ratio. A decrease in logP therefore does not necessarily mean that logD₇.₄ will decrease in parallel.

For example, incorporation of the ring oxygen of an oxetane may reduce the logP of the neutral molecule. However, if it also markedly lowers the pKₐ of an amine, the proportion of the neutral form at pH 7.4 may increase, and logD₇.₄ may remain unchanged or increase. Model studies and medicinal chemistry examples reported by Jeffries et al. show that changes in amine basicity can offset part of the reduction in logP produced by increased polarity.[4]

4.2 Oxetanes Are Generally More Hydrophilic Than the Corresponding All-Carbon Structures

Replacing a gem-dimethyl, cyclopropyl, or cyclobutylidene group with an oxetane introduces a ring oxygen in place of part of the hydrocarbon framework. The oxygen atom increases the molecular dipole and hydration capacity, and many matched molecular series therefore show lower logP values.

The magnitude of the reduction depends on the following factors:

① Whether the oxetane is located at the center or terminus of the molecule;

② Whether the ring oxygen is exposed to the solvent;

③ Whether the molecule forms intramolecular hydrogen bonds;

④ Whether an ionizable amine is located nearby;

⑤ Whether solid-state packing and lattice energy are altered;

⑥ The overall proportions of aromatic rings and alkyl groups in the molecule.

After introducing an oxetane, logP, logD, and solubility should therefore still be measured experimentally rather than inferred solely from oxygen content.

4.3 The Effect of Fluorination on Lipophilicity Depends on the Specific Structure

Jeffries et al. systematically compared isopropyl, cyclopropyl, and 3-oxetanyl model compounds. Their study showed that fluorination did not produce a uniform directional change in lipophilicity:

① Some monofluorinated structures had lower logP values than their nonfluorinated parent compounds;

② Gem-difluorinated structures may be more lipophilic than monofluorinated structures;

③ CF₃ groups increased lipophilicity in some series;

④ When fluorine is located close to oxygen, the relative orientations of the C—F and C—O dipoles influence hydration;

⑤ Branched structures may shield the C—F bond and reduce its dipolar interactions with water;

⑥ The same fluorination pattern may produce different effects in acyclic, cyclopropane, and oxetane structures.[4]

5 How Fluorinated Oxetanes Affect Metabolic Stability

5.1 Structural Factors That May Reduce Certain Oxidative Metabolic Pathways

Fluorinated 3,3-disubstituted oxetanes may alter metabolism through the following mechanisms:

① The quaternary carbon center at the 3-position has no C—H bond, reducing the likelihood of direct oxidation at this position;

② Replacement of a C—H bond with a C—F bond may suppress some oxidative processes that depend on hydrogen-atom abstraction;

③ The ring oxygen increases polarity and alters molecular conformation, potentially changing the orientation of the molecule within the active site of a metabolic enzyme;

④ Reduced lipophilicity may decrease binding to certain hydrophobic enzymes and nonspecific microsomal binding;

⑤ Blocking one metabolic site may redirect metabolism to another part of the molecule.

Cytochrome P450 enzymes are an important class of enzymes involved in oxidative drug metabolism. Fluorination can reduce certain localized CYP-mediated oxidation pathways, but this does not establish that the in vitro clearance or in vivo half-life of the entire molecule will necessarily improve.

The original study compared the in vitro metabolic stability of representative fluorinated oxetanes. Several tested structures retained a high proportion of the parent compound under the corresponding experimental conditions, although differences remained among the different fluorination patterns.[1]

5.2 Oxetane Itself May Also Become a Metabolic Site

Oxetane is not a completely metabolically inert structure. Toselli et al. found that some oxetanes can undergo ring opening catalyzed by human microsomal epoxide hydrolase (mEH), generating the corresponding diols. Relatively small changes in substituents could markedly alter the extent of ring opening.[5]

The overall reaction can be represented as follows:

Oxetane + H₂O → open-chain diol

This equation represents the overall material transformation rather than the complete sequence of enzyme-catalyzed steps.

mEH-mediated ring opening may sometimes redirect metabolic clearance from CYP-mediated oxidation to a hydrolytic pathway. Whether this shift is advantageous must be assessed using the following data:

① Half-life of the parent compound;

② In vitro intrinsic clearance;

③ Rate of formation of the ring-opened diol;

④ Proportions of other oxidative metabolites;

⑤ Major enzymes involved in metabolism;

⑥ Hepatocyte and in vivo pharmacokinetic results.

5.3 Metabolic Stability Should Be Evaluated Together with Metabolite Identification

Monitoring only the remaining proportion of the parent compound cannot establish why clearance has decreased or whether metabolism has shifted to a new site.

A more complete assessment generally includes the following:

6 Selection and Validation of Fluorinated Oxetane Building Blocks

6.1 Selecting Structures According to the Specific Optimization Problem

In a specific series of γ-secretase modulators, replacement of a tert-butyl group with a CF₃-oxetane reduced lipophilicity and improved lipophilic efficiency and metabolic stability. This result demonstrates that the motif can serve as a more polar substitute for tert-butyl, although the conclusion is limited to the corresponding molecular series.[6]

6.2 Establishing Matched Molecular Series

A matched molecular pair consists of two compounds in which most of the structure is identical and only one clearly defined structural unit is changed. To distinguish the respective effects of the ring oxygen and fluorine atoms, the following basic series can be established:

A. The original gem-dimethyl, cyclopropyl, or cyclobutylidene structure;

B. A nonfluorinated oxetane;

C. A monofluorinated oxetane or fluoromethyl-substituted oxetane;

D. A difluoromethyl or other polyfluorinated structure.

If the position of fluorine may affect the results, the following comparisons can be added:

· Ring fluorine versus side-chain fluorine;

· Fluoromethyl versus fluoroethyl;

· Linear versus branched fluoroalkyl groups;

· CHF, CHF₂, and CF₃;

· Primary, secondary, and cyclic amines.

This design allows the following effects to be distinguished separately:

① Changes caused by the ring oxygen;

② Changes caused by a single C—F bond;

③ Further changes resulting from an increased number of fluorine atoms;

④ Effects resulting from changes in the distance between fluorine and the amine.

6.3 Recommended Evaluation Sequence

Step 1: Confirm Chemical Stability

Examine whether the building block or target compound undergoes oxetane ring opening or defluorination during coupling, deprotection, purification, or storage.

Step 2: Measure Ionization and Lipophilicity

Measure the following parameters in parallel:

· pKₐ(BH⁺);

· logP;

· logD₇.₄;

· Solubility at different pH values.

This makes it possible to distinguish changes in intrinsic lipophilicity from changes in ionization state.

Step 3: Evaluate Membrane Permeability and Nonspecific Binding

Depending on the project requirements, assess:

① Artificial-membrane or cell-monolayer permeability;

② Efflux ratio;

③ Plasma protein binding;

④ Nonspecific microsomal binding.

Step 4: Evaluate Metabolic Stability

Compare:

① Human and experimental-animal liver microsomal stability;

② Hepatocyte clearance;

③ Major metabolites;

④ The involvement of CYPs and mEH.

Step 5: Reconfirm Target and Cellular Activity

Improved physicochemical properties do not guarantee that biological activity will be retained. Oxetane and C—F bonds alter substituent orientation, local dipoles, and hydrogen-bond-accepting ability. Target activity, cellular activity, and selectivity must therefore be reassessed.

6.4 Considerations in Data Analysis

1. A Decrease in pKₐ Should Not Be Considered Beneficial in Isolation

Reduced amine basicity may improve membrane permeability, but it may also decrease aqueous solubility, salt-forming ability, or ionic interactions required for target binding.

2. The Number of Fluorine Atoms Cannot Directly Predict logP

The effects of fluorination depend on position, conformation, branching, and adjacent functional groups. CHF, CHF₂, and CF₃ structures should be evaluated separately.

3. In Vitro Microsomal Stability Cannot Replace a Complete Pharmacokinetic Evaluation

In vivo exposure is also affected by intestinal absorption, transport, plasma protein binding, hepatic blood flow, renal clearance, and tissue distribution.

4. Elimination of a Metabolic Soft Spot Does Not Necessarily Reduce Total Clearance

After the original oxidative pathway is reduced, N-dealkylation, aromatic-ring hydroxylation, oxidation at other alkyl sites, or oxetane ring opening may occur.

5. A Bioisosteric Relationship Does Not Mean That Properties Are Identical

In specific structures, oxetane can replace gem-dimethyl groups, small carbocycles, or certain carbonyl motifs. However, such replacement may alter electron distribution, hydrogen-bond orientation, conformation, and metabolic pathways.

7 Classification and Research Applications of Representative Chemicals Related to the Design, Synthesis, Physicochemical Property Modulation, and Metabolic Evaluation of Fluorinated 3,3-Disubstituted Oxetane Building Blocks

Note: The products listed below include building blocks involved in the original study, reagents directly corresponding to the relevant reaction types, and additional products that may be used for condition screening and property evaluation. The inclusion of these additional products does not indicate that all of them have been experimentally validated with the specific substrates and reaction conditions described in Reference [1].

Table 1. Basic Oxetane Cores, Nonfluorinated Functional Building Blocks, and Structural Controls

Table 2. Fluorinated Oxetane Core Building Blocks and Functionalized Linker Units

Table 3. Reagents Related to Fluorination, Fluorohalogenation, and Fluoride Introduction

Table 4. Reagents Related to Carbon-Skeleton Construction, Protection, Activation, and Reduction

Table 5. Reagents Related to Lipophilicity, Buffer Systems, and In Vitro Metabolic Stability Evaluation

Note: The products listed above are representative Aladdin products for scientific research. Their specific use should be determined according to the product specification, batch-specific certificate of analysis (COA), and the intended reaction or evaluation system. Additional product specifications, grades, and COA information can be retrieved from the Aladdin website using the product name, CAS number, or catalog number.

References

[1] Litskan E. V., Lynnyk S. V., Shypov R. H., Vashchenko B. V., Hoida A. Ye., Klymenko-Ulianov O. O., Gorlova A. O., Granat D. S., Grygorenko O. O., Volochnyuk D. M., Ryabukhin S. V. Fine-Tuning of Physicochemical Properties of 3,3-Disubstituted Oxetanes Introducing Fluorine Atom(s) on the Building Blocks Level. Chemistry—A European Journal, 2025, 31: e202500940. DOI: 10.1002/chem.202500940.

[2] Litskan E. V., Semenchenko O. V., Lynnyk S. V., Granat D. S., Vashchenko B. V., Hoida A. Ye., Tolmachova D. A., Leha D. O., Grygorenko O. O., Volochnyuk D. M., Ryabukhin S. V. Oxetane as a Part of Modern Medicinal Chemistry Toolbox: The Advanced Synthesis of 3,3-Disubstituted Building Blocks. Organic Chemistry Frontiers, 2025, 12(13): 3775–3785. DOI: 10.1039/D5QO00572H.

[3] Wuitschik G., Carreira E. M., Wagner B., Fischer H., Parrilla I., Schuler F., Rogers-Evans M., Müller K. Oxetanes in Drug Discovery: Structural and Synthetic Insights. Journal of Medicinal Chemistry, 2010, 53(8): 3227–3246. DOI: 10.1021/jm9018788.

[4] Jeffries B., Wang Z., Troup R. I., Goupille A., Le Questel J.-Y., Fallan C., Scott J. S., Chiarparin E., Graton J., Linclau B. Lipophilicity Trends upon Fluorination of Isopropyl, Cyclopropyl and 3-Oxetanyl Groups. Beilstein Journal of Organic Chemistry, 2020, 16: 2141–2150. DOI: 10.3762/bjoc.16.182.

[5] Toselli F., Fredenwall M., Svensson P., Li X.-Q., Johansson A., Weidolf L., Hayes M. A. Hip To Be Square: Oxetanes as Design Elements To Alter Metabolic Pathways. Journal of Medicinal Chemistry, 2019, 62(16): 7383–7399. DOI: 10.1021/acs.jmedchem.9b00030.

[6] Mukherjee P., Pettersson M., Dutra J. K., Xie L., Am Ende C. W. Trifluoromethyl Oxetanes: Synthesis and Evaluation as a tert-Butyl Isostere. ChemMedChem, 2017, 12(19): 1574–1577. DOI: 10.1002/cmdc.201700333.

For more related articles, see below:

Innovations in the design of stereospecific drug molecular structures: Spirocyclic Scaffolds

Oxetane: Property-Window Optimization and a Building-Block Selection Guide (Tables 1–4)

Cyclic isomers--Azabicyclic molecular building blocks to aid drug design

Experimental Selection Logic for C-C Bond Construction: Understanding Fragment Coupling, Carbonyl Chain Extension, Olefination, and Late-Stage Bond-Forming Pathways by Bond-Forming Task

The Role of 7-Membered Nitrogen Heterocycles in Drug Discovery: Microstate Management, Conformational Bias, and Developability Trade-offs (with Research Selection Navigator and Product Tables 1–3)

One Atom Can Change a Drug’s Fate: Atom-Level Knobs and a Functional-Group Toolbox for Medicinal Chemistry (Methyl / Halogen Bonding / 3D Building Blocks / Late-Stage Fluorination + Product-Selection Tables)

Late-Stage Fluorination Toolbox: “Minimally Invasive Upgrades” for Lead Candidates： Four “Fluorine Knobs” → Two major routes (electrophilic vs nucleophilic) → An ¹⁸F-PET tracer branch → Selection navigation & representative product list

Multiple Physicochemical Properties Close to Benzamide, Conformational Orientation Closer to Sulfonamide: The Dual Bioisosteric Design Value of 3-Aryl-3-aminooxetanes